SCHEMBL5133113

SCHEMBL5133113

CCOCCOc1ccc([N+](=O)[O-])cc1C(=O)O

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
HTT P42858 1/20 0.51
ALDH1A1 P00352 8/20 0.48
MAPT P10636 2/20 0.48
KMT2A Q03164 3/20 0.46
LMNA P02545 2/20 0.46
NPSR1 Q6W5P4 2/20 0.46
PTK2B Q14289 1/20 0.46
CTSV O60911 2/20 0.45
CTSL P07711 2/20 0.45
PTGDR2 Q9Y5Y4 1/20 0.45
POLB P06746 1/20 0.45
KDM4E B2RXH2 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
RAB9A P51151 1/20 0.44
S1PR3 Q99500 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL732933 0.88 TP53 (0.55) TP53HTTALDH1A1MAPTKMT2A
SCHEMBL18113435 0.88 HTT (0.57) TP53HTTALDH1A1MAPTKMT2A
SCHEMBL5047690 0.86 ALDH1A1 (0.50) TP53HTTALDH1A1MAPTKMT2A
SCHEMBL7970263 0.85 S1PR3 (0.61) TP53HTTALDH1A1MAPTS1PR3
SCHEMBL28745869 0.84 S1PR3 (0.63) TP53HTTALDH1A1S1PR3
SCHEMBL13215174 0.82 ALDH1A1 (0.49) ALDH1A1MAPTKMT2ALMNANPSR1
SCHEMBL9638940 0.81 ALDH1A1 (0.56) ALDH1A1MAPTKMT2ALMNANPSR1
Ether SCHEMBL28274516 0.80 TP53 (0.58) TP53HTTALDH1A1MAPTKMT2A
SCHEMBL17538478 0.80 MAPT (0.70) ALDH1A1MAPTKMT2ALMNANPSR1
SCHEMBL11428399 0.80 TDP1 (0.59) TP53HTTALDH1A1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7319099-B2 Such as 1-{3-fluoro-4-[4-(2-isopropoxy-5-methanesulfonyl benzoyl)-piperazin-1-yl]-phenyl}-ethanone for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease HOFFMANN-LA ROCHE INC. (US) 2008-01-15 US disclosed